A major teaching hospital of Harvard Medical School

Slides:



Advertisements
Similar presentations
Prognostic significance of atrial fibrillation/flutter following acute myocardial infarction in patients with diabetes mellitus M.Gashi,E.Pllana,D.Kocinaj,S.Rexhepi.
Advertisements

Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation.
Mitral Valve Prolapse and Regurgitation
Edward Evans MD FACC Desoto Heart Clinic Disclosures Medtronic:speaker St. Jude Medical:speaker.
Underwriting Impact of New Advances in Valvular Heart Disease NEHOUA 2012 Michael Clark, FACC, FLMI, FBIM Chief Medical Director Swiss Re.
Echocardiographic Evaluation of LV Diastolic Function Natalie Bello, M.D. October 14, 2009.
Mitral Stenosis Emerson Liu Echo conference Nov. 5, 2008.
Echocardiographic Evaluation of Prosthetic Heart Valves
Screening and diagnosis of AF and stratifying stroke risk.
Atrial fibrillation Cardiology #2 Gimadeeva A.D..
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Mitral Stenosis. Etiology Most cases of mitral stenosis are due to rheumatic fever The rheumatic process causes immobility and thickening of the mitral.
ATRIAL FIBRILLATION Linda A. Snyder, MSN, CRNP. Definition: A common arrhythmia characterized by chaotic, rapid, discontinuous atrial depolarizations.
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Stenosis.
Percutaneous mitral valve repair using the MitraClip® device (e-valve)
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Bradycardia and Narrow Complex Tachycardia
Atrial Flutter Chris Caulfield AM Report 2/19/10.
Atrial fibrillation wavelets propagating in different directions disorganised atrial depolarisation without effective atrial contraction f waves
Atrial fibrillation Daniel Gutenberger M.D. Chief Medical Director American General, Milwaukee.
Arrhythmias: The Good, the Bad and the Ugly
Atrial Fibrillation. Outline Epidemiology Signs and Symptoms Etiology Differential Diagnosis Diagnostic Tests Classification Management.
NILOFAR RAHMAN, MD AMIT KUMAR, MD. DEFINITION  A SVT with uncoordinated atrial activation with constant deterioration of atrial mechanical function 
Atrial Fibrillation. Statistics 1.5% of people over 65 have AF 1.5% of people over 65 have AF 5x increased risk of stroke 5x increased risk of stroke.
The value of echocardiography in stroke management Asjid Qureshi, Specialist registrar to Dr S Nussey.
Ventricular Diastolic Filling and Function
Transthoracic Echocardiography in Cerebrovascular Disease Nisha I Parikh, MD MPH Noninvasive Imaging Conference May 14 th 2008.
Syncope & serial troponins don’t mix Cost Containment Project June 2015 Alex Raufi PGY2.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Perioperative management of atrial fibrillation
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
Atrial Fibrillation What is New in the 2006 ACC/AHA/ESC Guidelines HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation. May 2007.
Mitral Valve Disease Prof JD Marx UFS January 2006.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Causes of valve disease Valve regurgitation * Congenital *Acute rheumatic carditis *Chronic rhe. Carditis * I E *Syphlitic aortitis *Dilated Valve.
Author: Sebastian Valentin Costea University of Medicine and Pharmacy Targu Mures Assessment of thromboembolic risk factors in atrial fibrillation. Is.
#1009 Evaluation & Management of Atrial Fibrillation November 16 to 19 Stephen F. Schaal, MD Professor of Internal Medicine Division of Cardiology The.
Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.
Adult Medical-Surgical Nursing
Clinical Symptoms of Atrial Fibrillation according to QTc Interval Duration Kulik V.L., Yabluchansky N.I. Medical Clinics Chair National University of.
Ryan Hampton OMS IV January  Considerations Is MR severe? Is patient symptomatic? Is patient a good candidate? What is Left Ventricular function?
Exercise Management Atrial Fibrillation Chapter 9.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
1 Tedisamil for Conversion of Atrial Fibrillation Thomas A. Marciniak, M.D. Division of Cardiovascular and Renal Products U.S. Food & Drug Administration.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Cardioembolic Stroke: Diagnosis and Management
Asymptomatic mitral regurgitation When should you operate? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester.
Prevention of thromboembolism in AF ACC/AHA/ESC Guidelines Jin-Bae Kim, MD, PhD Arrhythmia Service, Division of Cardiology Cardiovascular Center, Kyung.
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Location of Thrombus in Non-Rheumatic Atrial Fibrillation SettingNAppendage(%) LA Body (%)Ref. TEE (21%) 1 (0.3%) Stoddard; JACC ’95 TEE233.
The Place of Closed Mitral Valvotomy Procedure in Facility Deprived Countries in the Modern PTMC/PMBV Era: 20 Years Experience at SMS Hospital, Jaipur,
Thanks ………… Echocardiographic Evaluation Of Prosthetic Cardiac Valves Dr Gaurav Kumar Chaudhary MD,DM( Cardiology) Assistant Professor Department of Cardiology.
Flow-Gradient Patterns in Severe Aortic Stenosis With Preserved Ejection Fraction Clinical Characteristics and Predictors of Survival Mackram F. Eleid,
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Original slides courtesy of Dr. Alex Morss
for Overall Prognosis Workshop Cochrane Colloquium, Seoul
Dr. M. A. Sofi MD; FRCP (London); FRCPEdin; FRCSEdin
DIASTOLIC DYSFUNCTION and DIASTOLIC HEART FAILURE
Screening and diagnosis of AF and stratifying stroke risk
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
Echocardiograms in syncope work-up
A. Epidemiology update:
Figure 2 Echocardiographic methods to estimate left atrial pressure
AMYLOID AND AF: WHAT ARE WE MISSING?
Correlation between endothelial function and hypertension
Atrial Fibrillation: An Escalating Cardiovascular Disease With Significant Clinical and Economic Consequences.
NICE 2014 Check pulse in patients presenting with:
Left atrial appendage flow during atrial fibrillation, as determined by pulsed Doppler during transoesophageal echocardiography. Left atrial appendage.
Presentation transcript:

A major teaching hospital of Harvard Medical School Role of Echocardiography in Atrial Fibrillation Kyle K. Pond December 15th, 2004

A major teaching hospital of Harvard Medical School Outline 1. Prevalence and epidemiology of atrial fibrillation 2. Use of transthoracic echocardiography -chamber sizes and function -valvular function 3. Use of transesophaeal echocardiography -detection of atrial thrombi -detection of other high risk factors -role timing of cardioversion -assessment of return of atrial mechanical function

A major teaching hospital of Harvard Medical School Atrial Fibrillation Common arrhythmia -estimated 2.3 million adults in US -approaching 200,000 hospital admissions/yr Disease of the elderly -4% of the population over the age of 60 -5/122,000 healthy Air Force recruits found to have atrial fibrillation on screening EKG (Hiss et al Circulation 1962) 20-26/100,000 deaths in Massachusetts in 1999 listed AF as contributing cause

A major teaching hospital of Harvard Medical School Epidemiology (cont) Atrial Fibrillation is BAD -Data from the FHS suggests that chronic AF confers an almost 2X increase in both overall and cardiovascular mortality (women>men). (Vaziri et al, Circ 1994).

My algorithm for treating atrial fibrillation A major teaching hospital of Harvard Medical School My algorithm for treating atrial fibrillation

A major teaching hospital of Harvard Medical School Potential Clinical Consequences 1. Thromboembolism 2. Tachycardia mediated cardiomyopathy 3. Hemodynamic deterioration 4. Symptoms

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Role of TTE in atrial fibrillation -Provides useful/prognostic information about cardiac anatomy, structure, and function

A major teaching hospital of Harvard Medical School Left Atrium -normal is <4.0cm -size of left atrium is important in helping to determine prognosis -increased size decreases the probability of maintaining sinus rhythm -increased LA size among the strongest predictors of development of new AF (HR 1.39 in previously mentioned FHS paper) -chronic AF, rheumatic MV dz, and severe LA enlargement (>6cm) have highest risk of recurrence (9) -ACC/AHA guidelines for anticoagulation in severe rheumatic MS in absence of AF-> LA size > 5.5 cm

A major teaching hospital of Harvard Medical School (cont) -LA size increases with progressive duration of AF -suggests AF “promotes” LAE -DCCV and maintenance of sinus rhythm are thought to possibly reverse LAE

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Summary -Evaluation of the LA size provides important prognostic information -ability to maintain sinus rhythm -likelihood of recurrence of AF or initial development of AF in someone without a prior hx -presence of significant LAE should not be an exclusion criteria for CV

A major teaching hospital of Harvard Medical School Left Ventricle -LVH, focal WMA, AS, pericarditis, or other causes of AF -LV dysfunction independently predicts stroke risk -based on meta-analysis of 1066 patients -in control groups-incidence of CVA -9.3%/yr in patients with mod/severe LV dysfxn -4.4%/yr in patients with no/mild LV dysfxn

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Mitral Valve TTE evaluates the degree of mitral valve disease -Gives prognostic information -Pts can initially present in afib,->can detect mitral stenosis -can affect duration of tx

A major teaching hospital of Harvard Medical School Mitral Regurgitation -evaluated by TTE -? protective against atrial fibrillation due to minimization of stasis in the LA and appendage Goldsmith et al, AJC 2000)

A major teaching hospital of Harvard Medical School TTE can help risk-stratify patients with atrial fibrillation -specifically low risk clinical patients may be at increased risk when TTE performed -SPAF data -low clinical, low echocardiographic risk (<1%/yr CVA) -low clinical, high echocardiographic risk (>5%/yr CVA)

A major teaching hospital of Harvard Medical School Bottom line: “The routine performance of transthoracic echocardiography is suggested for all patients presenting with their first episode of AF to obtain information regarding cardiac structure and function.” -WJM “UpToDate--2/04”

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Left Atrial Thrombi -In general poorly visualized by TTE (39-63% sensitive) -lower in LAA (<20% visualization of LAA on TTE). -TEE much better ->200 patients prior to MV repair/replacement -56% with H/O afib -sensitivity/specificity for left atrial thrombi were 100%/99% as compared with direct surgical visualization (Manning WJ et al, Arch Int Med 1995)

A major teaching hospital of Harvard Medical School LA thrombi in AF -seen in 10-15% of pts. with >72 hours of AF --much higher in pts with higher risk features --more likely if any of the following are visualized -dense LA smoke -low LAA velocity (usually <20cm/sec) -complex aortic plaque (SPAF-III TEE substudy)

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School TEE for identifing LA thrombus in AF -facilitated early cardioversion -in patients with acute thromboembolism (TE) ->40% of patients with acute TE and newly recognized AF were found to have LA thrombus -Routine TEE in this population is controversial at best

A major teaching hospital of Harvard Medical School TEE for facilitated early cardioversion -cardioversion->improves symptoms, cardiac function, ? decrease the risk of thrombus formation -DCCV without antecedent anticoagulation -approx 6% incidence of clinical TE

A major teaching hospital of Harvard Medical School Transesophageal Echocardiographically Facilitated Early Cardioversion From Atrial Fibrillation Using Short-Term Anticoagulation (Manning WJ et al, JACC 1995) -230 consecutive patients with atrial fibrillation >2 days or unknown duration -all underwent TEE-identifying 40 atrial thrombi in 34 patients (15%). -186/196 (95%) without thrombi had successful DCCV to NSR—none had a thromboembolic event Bottom Line-1st large scale study to show that TEE facilitated early cardioversion with short-term anticoagulation is safe and effective.

A major teaching hospital of Harvard Medical School AF of <48 hours duration -appears to be little role for TEE -375 patients with AF < 48 hours duration; no TEE -conversion to NSR in 95% -clinical thromboembolic event in 3 (0.8%) -similar to rate when on coumadin X 4 weeks

A major teaching hospital of Harvard Medical School Left Atrial Appendage Function - blood flow velocity is a quantifiable measure of stasis - low velocity associated with higher risk of thrombus formation - also associated with dense spontaneous echo contrast - low blood flow velocity (<15mm/sec) associated with increased risk of CVA (Shivelly BK, et al JACC 1996; 27:1772)

A major teaching hospital of Harvard Medical School Velocity predicts long term maintenance of sinus rhythm in pts with nonvalvular AF (Antonielle E, JACC 2002:39) -186 pts eventually successfully cardioverted to NSR. All had AF>48 hours. -TEE/TTE/clinical parameters obtained -at one year F/U 91/186 patients were in NSR

A major teaching hospital of Harvard Medical School

wave and appendage filling following the QRS. A major teaching hospital of Harvard Medical School Normal Doppler flow pattern in the left atrial appendage. There is appendage emptying following the P wave and appendage filling following the QRS.

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Spontaneous Echo Contrast -can be seen on TTE or more commonly TEE -“likely due to blood stasis in a cavity or related to alterations in blood components such as RBCs, fibrinogen, or platelets” (Manning WJ in Otto). -Fc receptor on platelet binding to fibrinogen -spontaneous contrast increases likelihood of LAA clot (Black et al JACC 1991) -spontaneous contrast increases likelihood of CVA (Chimowitz MI et al 1993) -not a “treatable” finding->marker for increased risk -coumadin and ASA have no effect on smoke -does reduce risk of CVA

A major teaching hospital of Harvard Medical School Is the presence of spontaneous echo contrast in the absence of LAA thrombus a contraindication (relative or otherwise) for subsequent DCCV?

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Return of Atrial Mechanical Function -Pulsed doppler transmitral echo can assess LA function -DCCV of AF of short duration leads to earlier return of atrial fxn -Longer duration AF takes longer for atrial function to recover -Led to recommendation of longer term anticoagulation post-DCCV -clinical utility unclear

A major teaching hospital of Harvard Medical School

A major teaching hospital of Harvard Medical School Other controversies/future questions 1. TEE before DCCV in patients with prior TEE evidence of thrombus and then subsequent adequate anticoagulation 2. Better why to risk stratify patients to ASA or coumadin based on TEE findings 3. Is DCCV worse for the LA than pharmacologic cardioversion?

A major teaching hospital of Harvard Medical School